文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

在乌干达拉凯,普遍存在 HIV 流行的人群中,较高的暴露前预防资格率和相关的 HIV 发病率。

High Rates of Pre-exposure Prophylaxis Eligibility and Associated HIV Incidence in a Population With a Generalized HIV Epidemic in Rakai, Uganda.

机构信息

Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.

Rakai Health Sciences Program, Entebbe, Uganda.

出版信息

J Acquir Immune Defic Syndr. 2022 Jul 1;90(3):291-299. doi: 10.1097/QAI.0000000000002946. Epub 2022 Mar 8.


DOI:10.1097/QAI.0000000000002946
PMID:35259129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9177156/
Abstract

BACKGROUND: The utility of using pre-exposure prophylaxis (PrEP) eligibility assessments to identify eligibility in general populations has not been well studied in sub-Saharan Africa. We used the Rakai Community Cohort Study to conduct a cross-sectional analysis to estimate PrEP eligibility and a cohort analysis to estimate HIV incidence associated with PrEP eligibility. METHODS: Based on Uganda's national PrEP eligibility tool, we defined eligibility as reporting at least one of the following HIV risks in the past 12 months: sexual intercourse with more than one partner of unknown HIV status; nonmarital sex act without a condom; sex engagement in exchange for money, goods, or services; or experiencing genital ulcers. We used log-binomial and modified Poisson models to estimate prevalence ratios for PrEP eligibility and HIV incidence, respectively. FINDINGS: We identified 12,764 participants among whom to estimate PrEP eligibility prevalence and 11,363 participants with 17,381 follow-up visits and 30,721 person-years (pys) of observation to estimate HIV incidence. Overall, 29% met at least one of the eligibility criteria. HIV incidence was significantly higher in PrEP-eligible versus non-PrEP-eligible participants (0.91/100 pys versus 0.41/100 pys; P < 0.001) and independently higher in PrEP-eligible versus non-PrEP-eligible female participants (1.18/100 pys versus 0.50/100 pys; P < 0.001). Among uncircumcised male participants, HIV incidence was significantly higher in PrEP-eligible versus non-PrEP-eligible participants (1.07/100 pys versus 0.27/100 pys; P = 0.001), but there was no significant difference for circumcised male participants. INTERPRETATION: Implementing PrEP as a standard HIV prevention tool in generalized HIV epidemics beyond currently recognized high-risk key populations could further reduce HIV acquisition and aid epidemic control efforts.

摘要

背景:在撒哈拉以南非洲,使用暴露前预防(PrEP)资格评估来确定一般人群中的资格的实用性尚未得到很好的研究。我们使用 Rakai 社区队列研究进行了横断面分析,以估计 PrEP 的资格,并进行了队列分析以估计与 PrEP 资格相关的 HIV 发病率。

方法:根据乌干达的国家 PrEP 资格工具,我们将以下至少一项过去 12 个月中的 HIV 风险定义为符合资格:与不明 HIV 状况的多个伴侣发生性关系;无保护措施的非婚姻性行为;为了换取金钱、货物或服务而发生性行为;或经历生殖器溃疡。我们使用对数二项式和修正泊松模型分别估计 PrEP 资格和 HIV 发病率的患病率比。

发现:我们在 12764 名参与者中确定了 PrEP 资格的患病率,在 11363 名参与者中确定了 17381 次随访和 30721 人年(pys)的观察结果,以估计 HIV 发病率。总体而言,29%的人符合至少一项资格标准。PrEP 合格参与者的 HIV 发病率明显高于非 PrEP 合格参与者(0.91/100 pys 与 0.41/100 pys;P<0.001),并且在 PrEP 合格女性参与者中也明显高于非 PrEP 合格参与者(1.18/100 pys 与 0.50/100 pys;P<0.001)。在未割礼的男性参与者中,PrEP 合格参与者的 HIV 发病率明显高于非 PrEP 合格参与者(1.07/100 pys 与 0.27/100 pys;P=0.001),但割礼男性参与者则没有差异。

解释:在目前公认的高危关键人群之外,将 PrEP 作为一种标准的 HIV 预防工具实施,可以进一步减少 HIV 的获得,并有助于控制艾滋病疫情。

相似文献

[1]
High Rates of Pre-exposure Prophylaxis Eligibility and Associated HIV Incidence in a Population With a Generalized HIV Epidemic in Rakai, Uganda.

J Acquir Immune Defic Syndr. 2022-7-1

[2]
Dynamics of Pre-Exposure (PrEP) Eligibility Because of Waxing and Waning of HIV Risk in Rakai, Uganda.

J Acquir Immune Defic Syndr. 2023-6-1

[3]
Brief Report: HIV Pre-exposure Prophylaxis Awareness and Use Among Rakai Community Cohort Study Youth Aged 15-24.

J Acquir Immune Defic Syndr. 2025-5-1

[4]
HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.

PLoS Med. 2021-2

[5]
Low awareness of oral and injectable PrEP among high-risk adolescent girls and young women in Kampala, Uganda.

BMC Infect Dis. 2022-5-16

[6]
Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South-Central Uganda.

J Int AIDS Soc. 2020-8

[7]
A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe.

J Int AIDS Soc. 2022-8

[8]
HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project.

J Int AIDS Soc. 2020-10

[9]
Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.

Lancet HIV. 2019-6-6

[10]
HIV Risk and Pre-Exposure Prophylaxis Eligibility Among Emergency Department Patients.

AIDS Patient Care STDS. 2021-6

引用本文的文献

[1]
Age and gender profiles of HIV infection burden and viraemia: novel metrics for HIV epidemic control in African populations with high antiretroviral therapy coverage.

Int J Epidemiol. 2025-6-11

[2]
Pre-exposure prophylaxis (PrEP) awareness, use, and discontinuation among Lake Victoria fisherfolk in Uganda: A cross-sectional population-based study.

PLOS Glob Public Health. 2025-5-9

[3]
Prevalence of Paid Sex and Associated Factors Among Women and Men Attending HIV Voluntary Counseling and Testing in Kinshasa, Democratic Republic of the Congo: A Prospective Cohort.

Arch Sex Behav. 2024-10

[4]
Pre-exposure prophylaxis (PrEP) knowledge, use, and discontinuation among Lake Victoria fisherfolk in Uganda: a cross-sectional population-based study.

medRxiv. 2024-3-30

[5]
Longitudinal population-level HIV epidemiologic and genomic surveillance highlights growing gender disparity of HIV transmission in Uganda.

Nat Microbiol. 2024-1

本文引用的文献

[1]
HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study.

Lancet HIV. 2021-7

[2]
Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South-Central Uganda.

J Int AIDS Soc. 2020-8

[3]
Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study.

Lancet HIV. 2020-2-19

[4]
Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs.

AIDS Behav. 2020-8

[5]
Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.

PLoS One. 2020-1-13

[6]
Estimation of new HIV diagnosis rates among high-risk, PrEP-eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United States.

J Int AIDS Soc. 2019-12

[7]
Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific.

HIV Med. 2020-7

[8]
Long-acting injectable cabotegravir for the prevention of HIV infection.

Curr Opin HIV AIDS. 2020-1

[9]
Impact of combination HIV interventions on HIV incidence in hyperendemic fishing communities in Uganda: a prospective cohort study.

Lancet HIV. 2019-9-15

[10]
Global implementation of PrEP for HIV prevention: setting expectations for impact.

J Int AIDS Soc. 2019-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索